8 / 182
OUR
GEOGRAPHIC SPREAD
The South African private
pharmaceutical market, as measured
by IMS MAT June 2016, is worth
R35,5 billion, with 6,7 % value and
0,4% volume growth.
Adcock Ingram holds a market share of 9,0% in value and 21,4% in
volume. Our operations are spread throughout the African continent
but our manufacturing facilities are based in South Africa and India
The head office for the Group is located in Midrand, South Africa.
MARKET OVERVIEW
Sales and marketing
Our sales and marketing activities are
conducted out of our office in Midrand.
ACTIVITIES
Distribution
Adcock Ingram has
a state-of-the-art
distribution system,
designed to distribute
the Company’s
products, as well as
those of its contracted
partners, direct to all
customers.
Manufacturing
We have four manufacturing
facilities
Durban
Johannesburg
Pretoria
Polokwane
CapeTown
Port Elizabeth
Kimberley
Bloemfontein
Maseru
LESOTHO
Mmabatho
SOUTH AFRICA
SWAZILAND
NAMIBIA
BOTSWANA
Windhoek
Gaborone
Mbabane
The
high-volume liquids
facility
situated in
Clayville
is a state-of-the-art and
highly automated factory
primarily producing
liquids and effervescent
formulations.
The
Critical Care facility
situated in
Aeroton
produces intravenous fluids,
blood bags, renal dialysis products and
small-volume parenterals.
The
tablet and capsule facility
located in
Wadeville
is focused,
amongst others, on the
manufacturing of anti-retroviral
medicines.
Consumer
competes in
the Fast Moving Consumer
Goods (FMCG) space and
includes market-leading
brands such as Panado
and Bioplus.
Over the Counter
focuses on brands sold
predominantly in the
pharmacy market, where
the pharmacist plays a
role in the product choice
and includes brands like
Corenza and Citro-Soda.
The
Prescription
portfolio comprises
products prescribed by
medical practitioners and
includes a range of quality
and affordable generic
medicines.
The
Hospital
portfolio has
a long history in the Group
based on an agreement
with Baxter which
positions Adcock Ingram
as a leading supplier of
critical care products,
including intravenous
solutions, blood collection
products and renal dialysis
systems.
ABOUT US
(continued)
4 |
Integrated Report 2016